| Direct Competitor Comparison | |
|---|
| BAX | BDX | FMS | GRFS | Industry |
|---|
| Market Cap: | 39.38B | 19.65B | 21.18B | 18.14B | 347.90M |
|---|
| Employees: | 51,000 | 29,555 | 86,855 | 11,418 | 396.00 |
|---|
| Qtrly Rev Growth (yoy): | 0.02 | 0.04 | 0.06 | 0.03 | 0.44 |
|---|
| Revenue (ttm):
| 14.25B | 7.85B | 14.29B | 3.42B | 133.82M |
|---|
| Gross Margin (ttm): | 0.52 | 0.52 | 0.34 | 0.51 | 0.62 |
|---|
| EBITDA (ttm): | 4.00B | 2.15B | 2.78B | 1.03B | -49.71M |
|---|
| Operating Margin (ttm):
| 0.23 | 0.21 | 0.15 | 0.26 | -0.17 |
|---|
| Net Income (ttm): | 2.29B | 1.13B | 1.04B | 362.72M | N/A |
|---|
| EPS (ttm): | 4.14 | 7.51 | 1.69 | 0.53 | -0.13 |
|---|
| P/E (ttm): | 17.57 | 13.49 | 20.35 | 50.52 | 21.75 |
|---|
| PEG (5 yr expected): | 1.68 | 1.97 | 1.58 | N/A | 1.20 |
|---|
| P/S (ttm): | 2.78 | 2.50 | 1.47 | 5.29 | 10.55 |
|---|
|
| BDX = Becton, Dickinson and Company | | FMS = Fresenius Medical Care AG & Co. KGAA | | GRFS = Grifols, S.A. | | Industry = Medical Instruments & Supplies | |
| Health Care Services Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Centers for Medicare & Medicaid Services | Private |
|---|
| Blue Cross and Blue Shield Association | Private |
|---|
| UK National Health Service | Private |
|---|
| UnitedHealth Group Incorporated | UNH | 62.60 | -0.00 | 63.80B | 12.20 |
|---|
| Caremark Pharmacy Services | Private |
|---|
| Kaiser Foundation Health Plan, Inc. | Private |
|---|
| HCA Holdings, Inc. | HCA | 37.67 | 0.00 | 16.79B | 12.35 |
|---|
| WellPoint Inc. | WLP | 78.57 | 0.01 | 23.58B | 9.27 |
|---|
| Aetna Inc. | AET | 60.24 | -0.00 | 19.60B | 12.44 |
|---|
|
| News on Direct Competitors | |
|---|
- BDX
- Wright Medical Stays Neutral Zacks Wed 1:40pm
- GRFS
- Grifols presents positive results from study of Prolastin at theflyonthewall.com Wed 8:49am
- GRFS
- InPlay: Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency Briefing.com Wed 8:48am
- GRFS
- Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency PR Newswire Wed 8:47am
- GRFS
- Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency CNW Group Wed 8:47am
- BDX
- BD Issues 2012 Sustainability Report PR Newswire Wed 8:00am
- FMS
- Fresenius Medical Care Prepared to Provide Uninterrupted Care for Dialysis Patients with the Onset of an Active Storm Season Business Wire Tue 4:15pm
- BDX
- THOR Downgraded to Underperform Zacks Tue 2:00pm
- BDX
- BD Board Declares Dividend PR Newswire Tue 11:25am
- GRFS
- Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin™ Business Wire Tue 7:00am
- BDX
- FDA Nod for Thoratec Controller Zacks Mon, May 20
- FMS
- Fresenius Medical Care Wins Multiple National Awards for Outstanding Patient Case Management Business Wire Mon, May 20
- FMS
- Fresenius Teams with ApolloMed Zacks Wed, May 15
- FMS
- FMS, COO, RMD, THC And HCA, Pushing Health Services Industry Downward at TheStreet Wed, May 15
- FMS
- Apollo Medical Holdings and Fresenius Medical Care Partner to Improve the Health of ApolloMed ACO Patients with End-Stage Renal Disease PR Newswire Tue, May 14
All Headlines for these symbols... Currency in USD. | |
|
0.30%